flumazenil has been researched along with sch 23390 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McGregor, IS; van Nieuwenhuijzen, PS | 1 |
Furuyashiki, T; Miyamoto, C; Narumiya, S; Ohinata, K; Suzuki, C | 1 |
2 other study(ies) available for flumazenil and sch 23390
Article | Year |
---|---|
Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry.
Topics: Animals; Baclofen; Benzazepines; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Flumazenil; Hypothermia; Illicit Drugs; Male; Methamphetamine; Morpholines; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Rats; Rats, Wistar; Ritanserin; Sodium Oxybate; Telemetry | 2009 |
Central PGE2 exhibits anxiolytic-like activity via EP1 and EP4 receptors in a manner dependent on serotonin 5-HT1A, dopamine D1 and GABAA receptors.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Benzazepines; Bicuculline; Brain; Dinoprostone; Flumazenil; GABA Modulators; GABA-A Receptor Antagonists; Male; Mice; Mice, Knockout; Neuropsychological Tests; Piperazines; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D1; Receptors, GABA-A; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Serotonin Antagonists | 2011 |